179 related articles for article (PubMed ID: 24118870)
1. Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness.
Kakouros N; Kickler TS; Laws KM; Rade JJ
J Thromb Haemost; 2013 Oct; 11(10):1814-22. PubMed ID: 24118870
[TBL] [Abstract][Full Text] [Related]
2. Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?
Pendyala LK; Loh JP; Lhermusier T; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
Am Heart J; 2014 Oct; 168(4):545-51. PubMed ID: 25262265
[TBL] [Abstract][Full Text] [Related]
3. The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions.
Janssen PW; Bergmeijer TO; Godschalk TC; Le TT; Breet NJ; Kelder JC; Hackeng CM; Ten Berg JM
J Thromb Haemost; 2017 Apr; 15(4):618-623. PubMed ID: 28135786
[TBL] [Abstract][Full Text] [Related]
4. Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
J Thromb Haemost; 2010 Jan; 8(1):37-42. PubMed ID: 19818001
[TBL] [Abstract][Full Text] [Related]
5. A comparison of INNOVANCE® PFA P2Y and VerifyNow P2Y12 assay for the assessment of clopidogrel resistance in patients undergoing percutaneous coronary intervention.
Jang J; Lim J; Chang K; Kim Y; Kim M; Park HI; Kim J; Shin S
J Clin Lab Anal; 2012 Jul; 26(4):262-6. PubMed ID: 22811359
[TBL] [Abstract][Full Text] [Related]
6. Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel.
Bouman HJ; Parlak E; van Werkum JW; Breet NJ; ten Cate H; Hackeng CM; ten Berg JM; Taubert D
J Thromb Haemost; 2010 Mar; 8(3):482-8. PubMed ID: 20040042
[TBL] [Abstract][Full Text] [Related]
7. Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Puerto Rican Hispanics.
Hernandez-Suarez DF; Scott SA; Tomey MI; Melin K; Lopez-Candales A; Buckley CE; Duconge J
Ther Adv Cardiovasc Dis; 2017 Sep; 11(9):235-241. PubMed ID: 28675986
[TBL] [Abstract][Full Text] [Related]
8. High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests.
Jover E; Rodríguez JM; Bernal A; Arroyo AB; Iniesta JA; Guiú IS; Martínez C; Vicente V; Lozano ML; Rivera J
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):604-11. PubMed ID: 24717421
[TBL] [Abstract][Full Text] [Related]
9. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
[TBL] [Abstract][Full Text] [Related]
10. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
11. The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis.
Liu Z; Xiang Q; Mu G; Xie Q; Zhou S; Wang Z; Chen S; Hu K; Gong Y; Jiang J; Cui Y
Platelets; 2020; 31(1):3-14. PubMed ID: 30744477
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L
PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259
[TBL] [Abstract][Full Text] [Related]
13. Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays.
Danielak D; Komosa A; Tomczak A; Graczyk-Szuster A; Lesiak M; Główka F; Karaźniewicz-Łada M
Scand J Clin Lab Invest; 2017 May; 77(3):190-198. PubMed ID: 28276728
[TBL] [Abstract][Full Text] [Related]
14. Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients.
Paniccia R; Antonucci E; Gori AM; Marcucci R; Giglioli C; Antoniucci D; Gensini GF; Abbate R; Prisco D
J Thromb Haemost; 2007 Sep; 5(9):1839-47. PubMed ID: 17723123
[TBL] [Abstract][Full Text] [Related]
15. Response to antiplatelet therapy is independent of endogenous thrombin generation potential.
Gremmel T; Panzer S; Steiner S; Seidinger D; Koppensteiner R; Pabinger I; Kopp CW; Ay C
Thromb Res; 2013 Jul; 132(1):e24-30. PubMed ID: 23623170
[TBL] [Abstract][Full Text] [Related]
16. Does the VerifyNow P2Y12 assay overestimate "therapeutic response" to clopidogrel? Insights using short thrombelastography.
Khanna V; Hobson A; Mikael R; Sambu N; Englyst N; Curzen N
Thromb Haemost; 2014 Jun; 111(6):1150-9. PubMed ID: 24671606
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care platelet function testing predicts bleeding in patients exposed to clopidogrel undergoing coronary artery bypass grafting: Verify pre-op TIMI 45--a pilot study.
Reed GW; Kumar A; Guo J; Aranki S; Shekar P; Agnihotri A; Maree AO; McLean DS; Rosenfield K; Cannon CP
Clin Cardiol; 2015 Feb; 38(2):92-8. PubMed ID: 25655085
[TBL] [Abstract][Full Text] [Related]
18. Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
Yao Y; Zhang JH; Tang XF; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Wang M; Gao RL; Yuan JQ
Chin Med J (Engl); 2016 Oct; 129(19):2269-74. PubMed ID: 27647183
[TBL] [Abstract][Full Text] [Related]
19. The effect of acenocoumarol on the antiplatelet effect of clopidogrel.
Dewilde WJ; Janssen PW; Bergmeijer TO; Kelder JC; Hackeng CM; ten Berg JM
Thromb Haemost; 2015 Oct; 114(4):708-16. PubMed ID: 26177793
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
